Euronext N.V.

Earnings Release • Feb 4, 2011

CONTACT | Media: +31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels) +351.217.900.029 (Lisbon), +44.20.7379.2789 (London) +1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris)

CONTACT | Investor Relations: +1.212.656.5700 (New York) +33.1.49.27.58.60 (Paris)

NYSE Euronext Announces Trading Volumes for January 2011

Global Derivatives Averaged 9.0 Million Contracts per Day in January European Derivatives Volumes Down 8% vs. Prior Year; Up 42% Sequentially European Cash Trading Volumes Up 28%, U.S. Cash Down 12% vs. Prior Year

February 4, 2011 – NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for January 20111 . Global derivatives average daily volume ("ADV") of 9.0 million contracts traded per day in January 2011 decreased 2.7% versus the prior year, but increased 35.6% sequentially. The decrease in global derivatives ADV versus prior year levels was driven primarily by a 7.5% decrease in European derivatives, partially offset by a 3.0% increase in U.S. equity options ADV. The strong sequential increase was driven by a 78.0% increase in European fixed income derivatives and a 29.5% increase in U.S. equity options. Cash equities ADV in January 2011 was mixed, with European cash ADV increasing 27.8% and U.S. cash trading volumes decreasing 12.2% from January 2010 levels.

Highlights

• NYSE Euronext global derivatives ADV in January 2011 of 9.0 million contracts decreased 2.7% compared to January 2010, but increased 35.6% from December 2010 levels.
• NYSE Euronext European derivatives products ADV in January 2011 of 4.7 million contracts decreased 7.5% compared to January 2010, but increased 41.9% from December 2010 levels. Total European fixed income products ADV in January 2011 of 2.6 million contracts decreased 4.3% compared to January 2010, but increased 78.0% from December 2010. Total equity products ADV of 2.0 million contracts in January 2011 decreased 12.5% compared to January 2010, but increased 12.8% from December 2010. Total commodities products ADV of 74,000 contracts in January 2011 increased 48.0% compared to January 2010.
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.4 million contracts in January 2011 increased 3.0% compared to January 2010 levels and increased 29.5% from December 2010. NYSE Euronext's U.S. options exchanges accounted for 24.5% of total U.S. consolidated equity options trading in January 2011, down from 27.8% in January 2010, but up from 23.1% recorded in December 2010.
• NYSE Euronext European cash products ADV of 1.8 million transactions in January 2011 increased 27.8% compared to January 2010 and increased 44.1% from December 2010.

¹ All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

• NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.4 billion shares in January 2011 decreased 12.2% compared to January 2010, but increased 18.2% compared to December 2010. NYSE Euronext's Tape A matched market share in January 2011 was 33.9%, down from 34.3% in January 2010 and down from 35.0% in December 2010.
• There were a total of 21 trading days in Europe and 20 trading days in the U.S. in January 2011, compared to 20 trading days in Europe and 19 trading days in the U.S. in January 2010.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in January 2011 was 4.7 million futures and options contracts, a decrease of 7.5% from January 2010, but an increase of 41.9% from December 2010. The 4.7 million in futures and options contracts ADV in January 2011 consisted of 3.7 million contracts executed through our full-service LIFFE CONNECT trading platform and 1.0 million contracts, or 20.4%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products.
• Total fixed income products ADV of 2.6 million contracts in January 2011 decreased 4.3% from January 2010, but increased 78.0% from December 2010.
• Total equity products (including Bclear) ADV of 2.0 million contracts in January 2011 decreased 12.5% compared to January 2010, but increased 12.8% from December 2010. The 2.0 million contracts in equity products ADV consisted of 1.5 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The 1.5 million contracts in individual equity products ADV consisted of 0.8 million in futures contracts, which represented a 6.6% decrease compared to January 2010 and 0.7 million in options contracts, which represented a 15.8% decrease compared to January 2010. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe.
• Total commodities products ADV of 74,000 contracts in January 2011 increased 48.0% compared to January 2010.

U.S. Derivatives

• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.4 million contracts in January 2011 increased 3.0% compared to January 2010 and increased 29.5% compared to December 2010.
• Total U.S. consolidated equity options ADV increased 16.7% to 17.7 million contracts in January 2011 compared to January 2010 and increased 21.8% compared to December 2010.
• NYSE Euronext's U.S. options exchanges accounted for 24.5% of the total U.S. consolidated equity options trading in January 2011, down from 27.8% in January 2010, but up from 23.1% in December 2010.
• NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in January 2011 was approximately 14,200 contracts, compared to 22,200 contracts in January 2010.

Cash Trading European Cash • NYSE Euronext European cash products ADV of 1.8 million transactions in January 2011 increased 27.8% compared to January 2010 and increased 44.1% compared to December 2010.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in January 2011 decreased 12.2% to 2.4 billion shares compared to January 2010, but increased 18.2% from December 2010.
• NYSE Euronext's Tape A matched market share in January 2011 was 33.9%, down from 34.3% in January 2010 and down from 35.0% in December 2010.

Exchange Traded Products

• NYSE Euronext U.S. matched exchange-traded products ADV (included in volumes for Tape B and Tape C) of 270 million shares in January 2011 decreased 22.3% compared to January 2010, but increased 26.0% compared to December 2010.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-fourth of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: http://www.nyx.com.

Cautionary Note Regarding Forward-Looking Statements

This press release August contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2010 ("document de référence") filed with the French Autorité des Marchés Financiers (Filed on April 22, 2010 under No. D.10-0304), 2010 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results August be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

	Average Daily Volume			Total Volume			Average Daily Volume		Total Volume
(Unaudited; contracts in thousands)	Jan-11	Jan-10	% Chg	Jan-11	Jan-10	% Chg	YTD 2011	% Chg vs. YTD 2010	YTD 2011	% Chg vs. YTD 2010
Number of Trading Days - European Markets Number of Trading Days - U.S. Markets	21 20	20 19		21 20	20 19		21 20		21 20
European Derivatives Products	4,688	5,066	-7.5%		98,441 101,315	-2.8%	4,688	-7.5%	98,441	-2.8%
of which Bclear	954	1,060	-9.9%	20,044	21,197	-5.4%	954	-9.9%	20,044	-5.4%
Total Fixed Income Products	2,622	2,740	-4.3%	55,060	54,796	0.5%	2,622	-4.3%	55,060	0.5%
Short Term Interest Rate Products Medium and Long Term Interest Rate Products 1	2,515 106	2,648 91	-5.0% 16.3%	52,825 2,234	52,967 1,829	-0.3% 22.1%	2,515 106	-5.0% 16.3%	52,825 2,234	-0.3% 22.1%
Total Equity Products 2	1,991		2,276 -12.5%	41,821	45,515	-8.1%	1,991	-12.5%	41,821	-8.1%
Individual Equity Products	1,470		1,658 -11.4%	30,863	33,164	-6.9%	1,470	-11.4%	30,863	-6.9%
Futures Options	750 720	804	-6.6% 855 -15.8%	15,753 15,110	16,072	-2.0% 17,092 -11.6%	750 720	-6.6% -15.8%	15,753 15,110	-2.0% -11.6%
Equity Index Products	522		618 -15.5%	10,958		12,351 -11.3%	522	-15.5%	10,958	-11.3%
of which Bclear	954	1,060	-9.9%	20,044	21,197	-5.4%	954	-9.9%	20,044	-5.4%
Individual Equity Products Futures	887 750	924 803	-4.1% -6.6%	18,617 15,747	18,490 16,056	0.7% -1.9%	887 750	-4.1% -6.6%	18,617 15,747	0.7% -1.9%
Options	137	122	12.3%	2,870	2,434	17.9%	137	12.3%	2,870	17.9%
Equity Index Products	68		135 -49.8%	1,427		2,707 -47.3%	68	-49.8%	1,427	-47.3%
Commodity Products	74	50	48.0%	1,560	1,004	55.3%	74	48.0%	1,560	55.3%
U.S. Derivatives Products
Equity Options 3
NYSE Euronext Options Contracts Total Consolidated Options Contracts	4,350 17,740	4,223 15,207	3.0% 16.7%	86,998 354,796 288,939	80,235	8.4% 22.8%	4,350 17,740	3.0% 16.7%	86,998 354,796	8.4% 22.8%
NYSE Group Share of Total	24.5%	27.8%		24.5%	27.8%		24.5%	-3.3%	24.5%	-3.3%
NYSE Liffe U.S.
Futures and Futures Options Volume	14.2		22.2 -36.2%	283		422 -32.8%	14.2	-36.2%	283.4	-32.8%
European Cash Products (trades in thousands)	1,768	1,384	27.8%	37,138	27,675	34.2%	1,768	27.8%	37,138	34.2%
Equities	1,699		1,324 28.4%	35,677		26,471 34.8%	1,699	28.4%	35,677	34.8%
Exchange-Traded Funds	20		17 17.7%	428		346 23.6%	20	17.7%	428	23.6%
Structured Products Bonds	44 5		37 19.8% 6 -15.0%	919 114		731 25.8% 127 -10.8%	44 5	19.8% -15.0%	919 114	25.8% -10.8%
U.S. Cash Products (shares in millions) 5	2,372	2,702	-12.2%	47,442 51,334		-7.6%	2,372	-12.2%	47,442	-7.6%
NYSE Listed (Tape A) Issues 4
Handled Volume 5	1,740	1,919	-9.3%	34,796	36,455	-4.6%	1,740	-9.3%	34,796	-4.6%
Matched Volume 6	1,644	1,767	-7.0%	32,872	33,572	-2.1%	1,644	-7.0%	32,872	-2.1%
Total NYSE Listed Consolidated Volume	4,849	5,144	-5.7%	96,985	97,738	-0.8%	4,849	-5.7%	96,985	-0.8%
Share of Total Consolidated Volume
Handled Volume 5 Matched Volume 6	35.9%	37.3%	-1.4%	35.9%	37.3%	-1.4%	35.9%	-1.4%	35.9%	-1.4%
	33.9%	34.3%	-0.4%	33.9%	34.3%	-0.4%	33.9%	-0.5%	33.9%	-0.5%
NYSE Arca & Amex (Tape B) Listed Issues
Handled Volume 5 Matched Volume 6	332 298	412 360	-19.3% -17.2%	6,648 5,968	7,824 6,848	-15.0% -12.8%	332 298	-19.3% -17.2%	6,648 5,968	-15.0% -12.8%
Total NYSE Arca & Amex Listed Consolidated Volume	1,288	1,581	-18.6%	25,753	30,043	-14.3%	1,288	-18.6%	25,753	-14.3%
Share of Total Consolidated Volume
Handled Volume 5	25.8%	26.0%	-0.2%	25.8%	26.0%	-0.2%	25.8%	-0.2%	25.8%	-0.2%
Matched Volume 6 Nasdaq Listed (Tape C) Issues	23.2%	22.8%	0.4%	23.2%	22.8%	0.4%	23.2%	0.4%	23.2%	0.4%
Handled Volume 5	300	371	-19.2%	5,997	7,055	-15.0%	300	-19.2%	5,997	-15.0%
Matched Volume 6	255	302	-15.7%	5,098	5,744	-11.2%	255	-15.7%	5,098	-11.2%
Total Nasdaq Listed Consolidated Volume	2,044	2,443	-16.3%	40,882	46,413	-11.9%	2,044	-16.3%	40,882	-11.9%
Share of Total Consolidated Volume
Handled Volume 5 Matched Volume 6	14.7% 12.5%	15.2% 12.4%	-0.5% 0.1%	14.7% 12.5%	15.2% 12.4%	-0.5% 0.1%	14.7% 12.5%	-0.5% 0.1%	14.7% 12.5%	-0.5% 0.1%
Exchange-Traded Funds 5,7
Handled Volume 5	300	394	-24.0%	5,996	7,492	-20.0%	300	-24.0%	5,996	-20.0%
Matched Volume 6	270	347	-22.3%	5,396	6,595	-18.2%	270	-22.3%	5,396	-18.2%
Total ETF Consolidated Volume	1,175	1,549	-24.1%	23,507	29,438	-20.1%	1,175	-24.1%	23,507	-20.1%
Share of Total Consolidated Volume
Handled Volume 5 Matched Volume 6	25.5% 23.0%	25.5% 22.4%	0.0% 0.6%	25.5% 23.0%	25.5% 22.4%	0.0% 0.6%	25.5% 23.0%	0.1% 0.6%	25.5% 23.0%	0.1% 0.6%

7 Data included in previously identified categories.

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.

5 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.

4 Includes all volume executed in NYSE Group crossing sessions.

NYSE Euronext Monthly Volume Summary

6 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.

1 Data includes currency products.

2 Includes Bclear trading Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.

3 Includes trading in U.S. equity options contracts, not equity-index options.